Also, based on the ample evidence of the independent association with mortality and cardiovascular disease in populations with and without CKD, the utility of serum cystatin C in identifying high-risk patients with CKD has been strongly advocated, beyond its use as a glomerular filtration biomarker (48-50). The gene discussed is CST3; the disease is chronic kidney disease.